SHARE

Ireland-UK, Innovation, 2018

UK-Ireland based Innovation Agency and Oxford AHSN’s status upgraded to core partner

15th July 2019

Effective 1 January 2018

EIT Health UK-Ireland partners Innovation Agency (AHSN for the North West Coast) and Oxford AHSN have successfully upgraded their status to core partner, effective 1 January 2018. Both the Innovation Agency and Oxford AHSN share EIT Health challenges of promoting healthy living, supporting active ageing and improving healthcare, through innovations that empower patients.
In particular, the Innovation Agency is a catalysts for the spread of innovation at pace and scale – improving health, generating economic growth and helping facilitate change across whole health and social care economies. The Innovation Agency connects regional networks of NHS and academic organisations, local authorities, the third sector and industry. It creates the right environment for relevant industries to work with the health and social care system.

The Oxford Academic Health Science Network (Oxford AHSN) works with a large and growing list of partners in the NHS, universities and industry within and beyond their region. Their strategy is designed to achieve four objectives with NHS England:

  1. Focus on the needs of patients and local populations;
  2. Speed up adoption of innovation into practice to improve clinical outcomes and patient experience;
  3. Build a culture of partnership and collaboration; and
  4. Create wealth.

You can read more about the Innovation Agency and Oxford AHSN’s assets in the relative cards in the UK-Ireland CLC’s Partnership Portfolio.

The recent upgrade of the Innovation Agency and Oxford AHSN’s status to core partners is wonderful news for the UK-Ireland community. The UK-Ireland CLC looks forward to supporting them with EIT Health projects and activities going forward.

For the partnership portfolio innovation agency click here

For the partnership portfolio oxford click here

For more information on Innovation Agency (AHSN for the North West Coast) click here

For more information on Oxford AHSN click here

EDIT-B launches the first blood test that can differentiate bipolar disorder from depression in France

EDIT-B launches the first blood test that can differentiate bipolar disorder from depression in France

Hear from those diagnosed with Bipolar Disorder

Find out more

EIT Health appoints four new Supervisory Board members

EIT Health appoints four new Supervisory Board members

Meet our new board members.

Find out more

María González Manso wins 2024 European Prize for Women Innovators

María González Manso wins 2024 European Prize for Women Innovators

Plus, three EIT Health-supported innovators recognised as runners up.

Find out more